5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine

C21H20F3N7O2 — CID 170182527

IUPAC5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine
SMILESFC(F)(F)COc1c(Nc2ncc(C3CC3)nc2-c2nn[nH]n2)cccc1C1=CCOCC1
InChIInChI=1S/C21H20F3N7O2/c22-21(23,24)11-33-18-14(12-6-8-32-9-7-12)2-1-3-15(18)27-19-17(20-28-30-31-29-20)26-16(10-25-19)13-4-5-13/h1-3,6,10,13H,4-5,7-9,11H2,(H,25,27)(H,28,29,30,31)
InChIKeyNXDPSTQOBVLMJY-UHFFFAOYSA-N
MW459.43 g/mol
LogP4.02
Rot. Bonds7

About 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine

5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine (PubChem CID 170182527) has the molecular formula C21H20F3N7O2 and a molecular weight of 459.43 g/mol. Its IUPAC name is 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine.

Molecular Properties

Compound Name5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine
PubChem CID170182527
Molecular FormulaC21H20F3N7O2
Molecular Weight459.43 g/mol
Exact Mass459.16
IUPAC Name5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine
SMILESFC(F)(F)COc1c(Nc2ncc(C3CC3)nc2-c2nn[nH]n2)cccc1C1=CCOCC1
InChIInChI=1S/C21H20F3N7O2/c22-21(23,24)11-33-18-14(12-6-8-32-9-7-12)2-1-3-15(18)27-19-17(20-28-30-31-29-20)26-16(10-25-19)13-4-5-13/h1-3,6,10,13H,4-5,7-9,11H2,(H,25,27)(H,28,29,30,31)
InChIKeyNXDPSTQOBVLMJY-UHFFFAOYSA-N
XLogP4.02
TPSA110.73 Ų
H-Bond Donors2
H-Bond Acceptors8
Rotatable Bonds7
Heavy Atoms33
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500459.43
LogP ≤ 54.02
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 108

Analyze 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine?
The IUPAC name of 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine (CID 170182527) is 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine.
What is the SMILES notation for 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine?
The canonical SMILES for 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine is FC(F)(F)COc1c(Nc2ncc(C3CC3)nc2-c2nn[nH]n2)cccc1C1=CCOCC1.
What is the InChIKey of 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine?
The InChIKey is NXDPSTQOBVLMJY-UHFFFAOYSA-N. The full InChI is InChI=1S/C21H20F3N7O2/c22-21(23,24)11-33-18-14(12-6-8-32-9-7-12)2-1-3-15(18)27-19-17(20-28-30-31-29-20)26-16(10-25-19)13-4-5-13/h1-3,6,10,13H,4-5,7-9,11H2,(H,25,27)(H,28,29,30,31).
What are the key properties of 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine?
5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine has a molecular weight of 459.43 g/mol, XLogP of 4.02, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 5-cyclopropyl-N-[3-(3,6-dihydro-2H-pyran-4-yl)-2-(2,2,2-trifluoroethoxy)phenyl]-3-(2H-tetrazol-5-yl)pyrazin-2-amine is sourced from PubChem (CID 170182527), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).